MARKET

APHA

APHA

Aphria Inc
NASDAQ

Real-time Quotes | Nasdaq Last Sale

13.18
-1.23
-8.54%
Opening 13:29 04/20 EDT
OPEN
14.80
PREV CLOSE
14.41
HIGH
14.98
LOW
13.16
VOLUME
11.07M
TURNOVER
--
52 WEEK HIGH
32.29
52 WEEK LOW
2.780
MARKET CAP
4.17B
P/E (TTM)
-8.6037
1D
5D
1M
3M
1Y
5Y
Cannabis Countdown: Top 10 Marijuana And Psychedelic Stock News Stories Of The Week, 4/20/2021
Welcome to the Cannabis Countdown, the Legal Marijuana Industry’s Number One Curated Weekly News Recap.
Benzinga · 2h ago
DJ Cannabis Stocks Rally Premarket After House Passes SAFE Banking Act -- MarketWatch
Dow Jones · 7h ago
If You Invested $1,000 In Aphria Stock One Year Ago, Here's How Much You'd Have Now
Investors who have owned stocks in the last year have generally experienced some big gains. In fact, the SPDR S&P 500 (NYSE: SPY) total return over the last 12 months is 50.3%. But there is no question some big-name stocks performed better than others alon...
Benzinga · 19h ago
Aphria Inc. stock outperforms competitors on strong trading day
Shares of Aphria Inc. rose 1.91% to $14.41 Monday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite...
marketwatch.com · 20h ago
Top 20 Trending Stocks On WallStreetBets As Of Monday, Apr. 19, 2021 (Via Swaggy Stocks)
Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment GameStop (GME) Clover Health Instruments (CLOV) Tesla (TSLA) Palantir Technologies (PLTR) Apple (AAPL) Peloton Interactive
Benzinga · 1d ago
Rise in Cannabis Use Leads to a Growing Demand for Effective Breathalyzer Technology
NEW YORK, April 19, 2021 /PRNewswire via COMTEX/ -- NEW YORK, April 19, 2021 /PRNewswire/ -- The cannabis industry has drastically changed over the course of...
PR Newswire - PRF · 1d ago
Aphria Shareholders Approve Tilray Merger
Aphria shareholders voted in favor of the proposed merger with rival Tilray, which will create the world’s largest cannabis company by revenue. Aphria (APHA) and Tilray (TLRY) first announced their proposed deal in December of last year. The required two-t...
SmarterAnalyst · 2d ago
10 Cheap Pharmaceutical Stocks For 2021
In this article we will take a look at the 10 cheap pharmaceutical stocks for 2021. You can skip our comprehensive analysis of the pharma industry and go directly to the 5 Cheap Pharmaceutical Stocks For 2021. Pharmaceutical companies have been in the spot...
Insider Monkey · 3d ago
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of APHA. Analyze the recent business situations of Aphria Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average APHA stock price target is 8.15 with a high estimate of 9.92 and a low estimate of 6.38.
EPS
Institutional Holdings
Institutions: 262
Institutional Holdings: 49.81M
% Owned: 15.72%
Shares Outstanding: 316.75M
TypeInstitutionsShares
Increased
62
12.58M
New
56
10.75M
Decreased
27
3.42M
Sold Out
24
1.27M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
+0.73%
Pharmaceuticals & Medical Research
+0.22%
Key Executives
Chairman/Chief Executive Officer/Director
Irwin Simon
Vice Chairman/Lead Director/Independent Director
Renah Persofsky
Chief Financial Officer
Carl Merton
Chief Operating Officer
James Meiers
Senior Vice President/Director of Sales/Director of Marketing
Bernard Yeung
Other
Denise Faltischek
Vice President/Director of Marketing
MEGAN Mccrae
Other
Christelle Gedeon
Vice President/Director of Sales
Bernie Yeung
Vice President
Maureen Berry
Other
.. ..
Other
Hendrik Knopp
Independent Director
Shlomo Bibas
Other
Tamara Macgregor
Independent Director
Jodi Butts
Independent Director
John Herhalt
Independent Director
David Hopkinson
Independent Director
Tom Looney
Independent Director
Thomas Looney
Independent Director
Walter Robb
No Data
About APHA
Aphria Inc is a Canada-based cannabis company. The Company's Canadian cannabis operations are comprised of its Aphria One greenhouse facility (Aphria One), facilities held through its wholly owned British Columbia-based subsidiary, Broken Coast Cannabis Ltd. (Broken Coast) and its Leamington-based subsidiary, 1974568 Ontario Limited (Aphria Diamond). Aphria One is the Company's greenhouse facility, which is located in Leamington, Ontario. Broken Coast's indoor cannabis production facility on Vancouver Island provides B.C. Bud, a cannabis brands in Canada. Its subsidiary, Avanti Rx Analytics Inc., provides testing services to its Canadian cannabis operations and allows to process, package, label and test cannabis oil as well as package, label and test dried cannabis for medicinal use. It also manufactures and distributes bottled, canned and draft craft beers. The Company has operations in Canada, Germany, Italy, Malta, Colombia and Argentina.

Webull offers kinds of Aphria Inc stock information, including NASDAQ:APHA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, APHA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading APHA stock methods without spending real money on the virtual paper trading platform.